(2E)-1-(4-ethoxyphenyl)-3-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

5-Benzyl-5-azaspiro[3.5]nonan-8-one, 95.0%, 1g

4-Chlorophenol, >=98 %, for synthesis, 2.5 kg, glass packaging

DIMETHYL 3-(BENZYLOXY)-4-OXO-4H-PYRAN-2,5-DICARBOXYLATE, 95.0%, 50g

2-Bromo-1,5-dimethoxy-3-methylbenzene, 97%, 250mg

Ethyl 5-chloropyrazine-2-carboxylate, 95.0%, 1g

2-chloro-N-(5-phenyl-1,2,4-thiadiazol-3-yl)acetamide, 95.0%, 1g

(2R,4R)-4-((tert-Butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 95+%, 500mg

2-methoxy-3,4-dihydropyrimidin-4-one, 95%, 5g

Ethyl 2-chloroethanimidoate hydrochloride, 95.0%, 500mg

5-Nitro-2-trifluoromethylbenzimidazole, 95.0%, 5g

3-(2,5-Difluorophenyl)propanoic acid, 95.0%, 25g

1-Benzyl-4-piperidone, 95.00%, 100g